High-frequency ultrasound (HIFU) developer EyeTechCare of Rillieux la Pape, France will be holding a HIFU symposium at the upcoming World Glaucoma Congress in Paris.
The session, which will be co-chaired by the president of the French Glaucoma Society and the head of ophthalmology at Tel Aviv University Medical School, will debate subjects such as:
- The potential of ultrasound as a cure for glaucoma
- HIFU technology
- The current glaucoma patient's perspective
- Therapeutic use of ultrasound circular cyclo-coagulation (UC3)
- Results of the first human clinical trial of EyeTechCare's EyeOP1 medical device
- Improvement of the standard of care
The session is scheduled for 30 June from 6 p.m. to 7 p.m. at the Palais des Congrès.
